Biotech Values

[mcbio]

All in all, while the mechanism of action is novel and slide 21 lists the advantages 30063 has over its competitors, is the data from the current phase 2 impressive enough to land a meaningful partnership?

What's going on with PYMX? Hadn't looked at them in awhile and now see market cap is down below $10M. Looks like they only had $7M in cash as of 9/30/12. Total boom-or-bust play at this point. I don't have the guts to take a position here myself; doesn't seem like they have any kind of leverage with such small cash balance. Looks like they didn't even hold a CC to discuss the 3Q12 results; how do you not hold a CC at this stage?